A case-control study of genetic, environmental, and occupational risk factors for Parkinson's disease (PD) was carried out in five European countries (Italy, Malta, Romania, Scotland, and Sweden) to explore the possible contribution of interactions among host and environmental factors in sporadic PD
Case-control study of the α-synuclein interacting protein gene and Parkinson's disease
✍ Scribed by Demetrius M. Maraganore; Matthew J. Farrer; Timothy G. Lesnick; Mariza De Andrade; James H. Bower; Dena Hernandez; John A. Hardy; Walter A. Rocca
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 71 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We conducted a case‐control study of the α‐synuclein–interacting protein gene (SNCAIP, also known as synphilin‐1) and Parkinson's disease (PD). A total of 319 PD cases and 195 controls were genotyped for four SNCAIP variants, including a microsatellite repeat in intron 4 and three restriction fragment length polymorphisms (RFLP) proximal to the 5′ terminal of exons 1, 4, and 6. None of the variants were found associated with PD overall. Global score statistics were not significant for four, three, and two loci haplotypes. All four loci were in linkage disequilibrium for cases, controls, or both groups combined (P < 0.0001). Recursive partitioning showed no interactions between variants of the SNCAIP gene and variants of the α‐synuclein gene (SNCA) or the parkin (PARK2) gene. © 2003 Movement Disorder Society
📜 SIMILAR VOLUMES
We investigated the association of Parkinson's disease (PD) with two estrogen receptor gene polymorphisms. In a sample of 319 unrelated PD cases and 196 control subjects including both men and women, we observed no association of PD with the estrogen receptor genotypes derived from XbaI and PvuII di
## Abstract An inverse association between coffee and Parkinson's disease (PD) has been reported. However, it remains uncertain why some but not all coffee drinkers are less susceptible to PD. We considered the possibility of a pharmacogenetic effect. In our study, we included 1,208 subjects (446 c